Skip to main content

Cyteir Therapeutics, Inc.

CYTDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001662244

Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Cyteir Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

CYT is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.

Institutional holders
38
−2 vs. Q3 2023
Shares held
12.8M
−1.07M (−7.7%) vs. Q3 2023
Total value
$38.9M
−$466.5K (−1.2%) vs. Q3 2023
New holders
8
11 more added
Sold out
10
5 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 38 institutions
Q1 2021: 0 institutionsQ2 2021: 33 institutionsQ3 2021: 38 institutionsQ4 2021: 48 institutionsQ1 2022: 52 institutionsQ2 2022: 45 institutionsQ3 2022: 37 institutionsQ4 2022: 30 institutionsQ1 2023: 32 institutionsQ2 2023: 39 institutionsQ3 2023: 41 institutionsQ4 2023: 38 institutionsQ1 2024: 4 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $38.9M
Q1 2021: $0Q2 2021: $352.6MQ3 2021: $344.1MQ4 2021: $253.4MQ1 2022: $83.8MQ2 2022: $56.8MQ3 2022: $34.6MQ4 2022: $28.5MQ1 2023: $23.9MQ2 2023: $41.7MQ3 2023: $46.3MQ4 2023: $38.9MQ1 2024: $11.2MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20244$11.2M
Q4 202338$38.9M
Q3 202341$46.3M
Q2 202339$41.7M
Q1 202332$23.9M
Q4 202230$28.5M
Q3 202237$34.6M
Q2 202245$56.8M
Q1 202252$83.8M
Q4 202148$253.4M
Q3 202138$344.1M
Q2 202133$352.6M
Q1 20210$0

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding CYT in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BML Capital Management, LLC3,250,008$9.88M7.80%00.0%Unchanged
Newtyn Management, LLC3,021,500$9.19M1.80%+521,056+20.8%Added
Gabelli Funds LLC1,110,050$3.37M0.03%+667,412+150.8%Added
Anson Funds Management LP1,096,422$3.33M0.69%−227,692−17.2%Reduced
Gabelli & Co Investment Advisers, Inc.1,026,000$3.12M0.59%+609,800+146.5%Added
Vanguard Group Inc687,391$2.09M0.00%+46,611+7.3%Added
Millennium Management LLC451,980$1.37M0.00%+451,980New
Walleye Capital LLC427,037$1.30M0.02%+73,121+20.7%Added
Laurion Capital Management LP316,201$961.3K0.03%−43,299−12.0%Reduced
Bulldog Investors, LLP200,000$608.0K0.20%00.0%Unchanged
Geode Capital Management, LLC177,930$541.0K0.00%+14,393+8.8%Added
Aldebaran Capital, LLC143,739$437.0K0.45%00.0%Unchanged
RBF Capital, LLC117,295$356.6K0.02%00.0%Unchanged
BlackRock Inc.91,578$278.4K0.00%+5,994+7.0%Added
Bank of America Corp89,304$271.5K0.00%+8,830+11.0%Added
Northern Trust Corp68,283$207.6K0.00%+34,094+99.7%Added
Squarepoint Ops LLC67,219$204.3K0.00%+16,341+32.1%Added
Bank of Montreal66,300$203.5K0.00%+66,300New
Pale Fire Capital SE57,597$175.1K0.03%00.0%Unchanged
CSS LLC55,359$168.3K0.01%−1,695−3.0%Reduced
State Street Corp46,153$140.3K0.00%00.0%Unchanged
Jane Street Group, LLC41,602$126.5K0.00%+41,602New
Bridgeway Capital Management, LLC32,800$99.7K0.00%+32,800New
Wittenberg Investment Management, Inc.28,588$86.9K0.03%00.0%Unchanged
Caas Capital Management LP26,175$79.6K0.08%00.0%Unchanged
Boston Family Office LLC24,197$74.0K0.01%00.0%Unchanged
Charles Schwab Investment Management Inc15,972$48.6K0.00%00.0%Unchanged
HRT Financial LP16,015$48.0K0.00%+16,015New
Landscape Capital Management, L.L.C.13,080$39.8K0.00%+13,080New
XTX Topco Ltd10,596$32.2K0.01%+10,596New
Royal Bank of Canada5,357$16.0K0.00%+5,357New
Tower Research Capital LLC (TRC)3,049$9.27K0.00%−3,868−55.9%Reduced
Lindbrook Capital, LLC2,006$6.10K0.00%00.0%Unchanged
Morgan Stanley1,000$3.04K0.00%00.0%Unchanged
Wolverine Asset Management LLC570$1.73K0.00%00.0%Unchanged
Wells Fargo & Company147$4470.00%+8+5.8%Added
JPMorgan Chase & Co124$3770.00%−372−75.0%Reduced
Qube Research & Technologies Ltd4$120.00%00.0%Unchanged
VR Advisory Services Ltd0$00.00%−1,072,968−100.0%Sold out
FMR LLC0$00.00%−826,758−100.0%Sold out
Novo Holdings A/S0$00.00%−676,379−100.0%Sold out
Acuitas Investments, LLC0$00.00%−329,164−100.0%Sold out
Cantor Fitzgerald, L. P.0$00.00%−132,496−100.0%Sold out
Alta Fundamental Advisers LLC0$00.00%−117,346−100.0%Sold out
Renaissance Technologies LLC0$00.00%−104,649−100.0%Sold out
Virtu Financial LLC0$00.00%−80,428−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−67,990−100.0%Sold out
Vazirani Asset Management LLC0$00.00%−15,770−100.0%Sold out
OUP Management Co., LLC––––Not filed